Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics

被引：44

作者：

Fröhlich, M

Hoffmann, MM

Burhenne, J

Mikus, G

Weiss, J

Haefeli, WE

机构：

[1] Univ Heidelberg, Dept Internal Med 6, D-69120 Heidelberg, Germany

[2] Univ Freiburg, Dept Med, Div Clin Chem, D-79106 Freiburg, Germany

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 58卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.2004.02159.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：443 / 444

页数：2

共 13 条

[1]

ANDERSON PL, 2004, 11 C RETR OPP INF SA

[2] The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin [J].

Backman, JT ;

Kivistö, KT ;

Olkkola, KT ;

Neuvonen, PJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) :53-58

[3] Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometry [J].

Burhenne, J ;

Riedel, KD ;

Martin-Facklam, M ;

Mikus, G ;

Haefeli, WE .

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 784 (02) :233-242

[4] Saquinavir soft-gel capsule - An updated review of its use in the management of HIV infection [J].

Figgitt, DP ;

Plosker, GL .

DRUGS, 2000, 60 (02) :481-516

[5]

Fitzsimmons ME, 1997, DRUG METAB DISPOS, V25, P256

[6] Oral contraception does not alter single dose saquinavir pharmacokinetics in women [J].

Fröhlich, M ;

Burhenne, J ;

Martin-Facklam, M ;

Weiss, J ;

von Wolff, M ;

Strowitzki, T ;

Walter-Sack, I ;

Haefeli, WE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (03) :244-252

[7] Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression [J].

Kuehl, P ;

Zhang, J ;

Lin, Y ;

Lamba, J ;

Assem, M ;

Schuetz, J ;

Watkins, PB ;

Daly, A ;

Wrighton, SA ;

Hall, SD ;

Maurel, P ;

Relling, M ;

Brimer, C ;

Yasuda, K ;

Venkataramanan, R ;

Strom, S ;

Thummel, K ;

Boguski, MS ;

Schuetz, E .

NATURE GENETICS, 2001, 27 (04) :383-391

[8] Genetic contribution to variable human CYP3A-mediated metabolism [J].

Lamba, JK ;

Lin, YS ;

Schuetz, EG ;

Thummel, KE .

ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (10) :1271-1294

[9] Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL [J].

Martin-Facklam, M ;

Burhenne, J ;

Ding, R ;

Fricker, R ;

Mikus, G ;

Walter-Sack, I ;

Haefeli, WE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) :576-581

[10]

MIKUS G, 2004, IN PRESS CLIN PHARMA

← 1 2 →